COST-EFFECTIVENESS ANALYSIS OF RALTEGRAVIR IN HIV-INFECTED TREATMENT NAIVE PATIENTS IN GREECE

被引：1
|
作者：
Athanasakis, K. [1 ]
Boubouchairopoulou, N. [1 ]
Retsa, M. P. [2 ]
Maiese, E. M. [3 ]
Elbasha, E. H. [4 ]
Kyriopoulos, J. [1 ]
机构：
[1] Natl Sch Publ Hlth, Athens, Greece
[2] MSD Hellas, Athens, Greece
[3] Merck & Co Inc, Whitehouse Stn, NJ USA
[4] Merck & Co Inc, Flourtown, PA USA
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.2506
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN65
引用
收藏
页码：A675 / A675
页数：1
相关论文
共 50 条
  • [41] Cost and cost-effectiveness of a real-world HCV treatment program among HIV-infected individuals in Myanmar
    Marquez, Lara K.
    Chaillon, Antoine
    Soe, Kyi Pyar
    Johnson, Derek C.
    Zosso, Jean-Marc
    Incerti, Andrea
    Loarec, Anne
    Nguyen, Aude
    Walker, Josephine G.
    Mafirakureva, Nyashadzaishe
    Lo Re III, Vincent
    Wynn, Adriane
    McIntosh, Craig
    Kiene, Susan M.
    Brodine, Stephanie
    Garfein, Richard S.
    Vickerman, Peter
    Martin, Natasha K.
    [J]. BMJ GLOBAL HEALTH, 2021, 6 (02):
  • [42] Raltegravir in HIV-infected patients with high vascular risk
    Olalla, Julian
    del Arco, Alfonso
    de la Torre, Javier
    Salas, Daniel
    Luis Prada, Jose
    Garcia-Alegria, Javier
    [J]. MEDICINA CLINICA, 2012, 138 (03): : 107 - 109
  • [43] COST-EFFECTIVENESS OF SURGICAL INTERVENTION FOR THERAPY-INDUCED FACIAL LIPOATROPHY IN HIV-INFECTED PATIENTS
    Massella, M.
    Scalone, L.
    Ivanovic, J.
    Narciso, P.
    Bellagamba, R.
    Fragola, V
    Tozzi, V
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A434 - A434
  • [44] COST EFFECTIVENESS ANALYSIS OF THE COMBINATION TENOFOVIR (TDF)/EMTRICITABINA (FTC) plus EFAVIRENZ (EFV) IN HIV-INFECTED NAIVE PATIENTS IN MEXICO
    Soto Molina, H.
    Pizarro, M.
    Vargas, G.
    Rizzoli, A.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A245 - A245
  • [45] Cost-effectiveness of earlier initiation of antiretroviral therapy for uninsured HIV-infected adults
    Schackman, BR
    Goldie, SJ
    Weinstein, MC
    Losina, E
    Zhang, H
    Freedberg, KA
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2001, 91 (09) : 1456 - 1463
  • [46] Pharmacokinetics and Pharmacodynamics of Once-Daily versus Twice-Daily Raltegravir in Treatment-Naive HIV-Infected Patients
    Rizk, Matthew L.
    Hang, Yaming
    Luo, Wen-Lin
    Su, Jing
    Zhao, Jing
    Campbell, Havilland
    Nguyen, Bach-Yen T.
    Sklar, Peter
    Eron, Joseph J., Jr.
    Wenning, Larissa
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (06) : 3101 - 3106
  • [47] Impact and Cost-Effectiveness of Culture for Diagnosis of Tuberculosis in HIV-Infected Brazilian Adults
    Dowdy, David W.
    Lourenco, Maria C.
    Cavalcante, Solange C.
    Saraceni, Valeria
    King, Bonnie
    Golub, Jonathan E.
    Bishai, David
    Durovni, Betina
    Chaisson, Richard E.
    Dorman, Susan E.
    [J]. PLOS ONE, 2008, 3 (12):
  • [48] Cost-effectiveness of malaria preventive treatment for HIV-infected pregnant women in sub-Saharan Africa
    Choi, Sung Eun
    Brandeau, Margaret L.
    Bendavid, Eran
    [J]. MALARIA JOURNAL, 2017, 16
  • [49] Cost-effectiveness of malaria preventive treatment for HIV-infected pregnant women in sub-Saharan Africa
    Sung Eun Choi
    Margaret L. Brandeau
    Eran Bendavid
    [J]. Malaria Journal, 16
  • [50] THE COST-EFFECTIVENESS OF TREATMENT FOR ASYMPTOMATIC HIV-INFECTED PERSONS - AZT AND PROPHYLAXIS FOR PNEUMOCYSTIS-CARINII PNEUMONIA
    FREEDBERG, KA
    TOSTESON, ANA
    COHEN, CJ
    COTTON, DJ
    [J]. MEDICAL DECISION MAKING, 1990, 10 (04) : 332 - 332
12345